Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioCardia, Inc.BCDA · Entity 7752 | Director | July 06, 2026 | July 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioCardia, Inc.
Report date July 06, 2026 · Filed July 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2036-07-06 | Direct | 23,729 |
Reported balance
After 2026-07-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-06 · Grant · Acquired 8,000 · Balance 23,729 F1: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. |
Filing footnotes · ownership attribution and instrument terms
F1: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2026 Filed Jul 8, 2026 01:44 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001437749-26-022962 · rdgdoc.xml · derivative · entry 1 Facteau Bill · CIK 0001997664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,729 Underlying: Common stock · 8,000 shares Expires 2036-07-06 F1 · derivative.exercise_date: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| December 08, 2025 Filed Dec 11, 2025 02:52 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $1.37 | $0.00 |
DisclosureSEC source: 0001437749-25-037470 · rdgdoc.xml · derivative · entry 1 Facteau Bill · CIK 0001997664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,729 Underlying: Common Stock · 12,000 shares Expires 2035-12-08 F1 · derivative.exercise_date: One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| April 23, 2025 Filed Apr 26, 2025 01:37 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseWarrant (right to buy) · Derivative | 13,123 | Not disclosed Strike: $1.91 | Not disclosed |
DisclosureSEC source: 0001437749-25-013199 · rdgdoc.xml · derivative · entry 2 Facteau Bill · CIK 0001997664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,123 Underlying: Common Stock · 13,123 shares Expires 2030-04-23 F1 · shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · price: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. F1 · derivative.underlying_shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| April 23, 2025 Filed Apr 26, 2025 01:37 UTC | BioCardia, Inc. BCDA · Entity 7752 | PurchaseCommon Stock | 13,123 | $1.91 | $24,999.32 |
DisclosureSEC source: 0001437749-25-013199 · rdgdoc.xml · nonDerivative · entry 1 Facteau Bill · CIK 0001997664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,123 F1 · shares: On April 23, 2025, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each share of common stock purchased. Read SEC document |
| October 11, 2024 Filed Oct 17, 2024 01:55 UTC | BioCardia, Inc. BCDA · Entity 7752 | GrantStock Option (right to buy) · Derivative | 829 | $0.00 Strike: $2.65 | $0.00 |
DisclosureSEC source: 0001437749-24-031408 · rdgdoc.xml · derivative · entry 1 Facteau Bill · CIK 0001997664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,729 Underlying: Common stock · 829 shares Expires 2034-10-11 F1 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| October 18, 2023 Filed Oct 19, 2023 21:01 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 12,434 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-23-028618 · rdgdoc.xml · derivative · entry 2 Facteau Bill · CIK 0001997664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,434 Underlying: Common Stock · 12,434 shares Expires 2033-10-18 F2 · derivative.exercise_date: One hundred percent of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| October 18, 2023 Filed Oct 19, 2023 21:01 UTC | BioCardia, Inc. BCDA;BCDAW · Entity 7752 | GrantStock Option (right to buy) · Derivative | 31,085 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001437749-23-028618 · rdgdoc.xml · derivative · entry 1 Facteau Bill · CIK 0001997664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,085 Underlying: Common Stock · 31,085 shares Expires 2033-10-18 F1 · derivative.exercise_date: One-third of the shares subject to the option vest and become exercisable on the one-year anniversary of the date of grant and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.